Magainin-2

Also known as: Magainin II, MAG2, Pexiganan precursor

An amphibian-derived antimicrobial peptide with potent antiparasitic and antibacterial properties.

Overview

Magainin-2 is a 23-amino acid antimicrobial peptide originally isolated from the skin of the African clawed frog (Xenopus laevis). It represents one of the most studied antimicrobial peptides with demonstrated activity against parasites, bacteria, fungi, and even some tumor cells.

Mechanism of Action

Magainin-2 adopts an amphipathic alpha-helical structure upon contact with lipid membranes. It creates pores in parasitic and microbial membranes through the 'toroidal pore' model, leading to membrane disruption, ion leakage, and cell death. The peptide preferentially targets negatively charged membranes, sparing host cells.

Pharmacokinetics

Rapid membrane binding kinetics. Subject to proteolytic degradation. Various analogs have been developed with improved stability.

Dosing Protocols

Note: These are research protocols from literature. This is not medical advice.

1

Research Protocol

Dose

1-10 mg/mL topical

Frequency

1-2x daily

Duration

Based on infection

Concentration varies by application

Stacking Recommendations

Peptides that may be combined based on complementary mechanisms in research settings.

Rationale: Synergistic antimicrobial action

Synergy: Different membrane disruption mechanisms provide broader coverage

Research Areas

Parasitic InfectionsAntimicrobial ResearchCancer ResearchDrug-Resistant PathogensTopical Infections

Key Research Findings

  • 1Effective against Plasmodium falciparum (malaria parasite) at low micromolar concentrations
  • 2Demonstrated activity against Leishmania, Giardia, and Trichomonas
  • 3Pexiganan, a derivative, reached Phase 3 clinical trials for diabetic foot infections
  • 4Minimal resistance development due to membrane-targeting mechanism
  • 5Synergistic with conventional antiparasitic agents

Side Effects & Contraindications

Reported Side Effects

  • Local irritation
  • Redness at application site

Contraindications

  • Hypersensitivity to amphibian-derived peptides
  • Application to large open wounds (systemic absorption)

Safety Considerations

Research compound. Generally selective for pathogen membranes but high concentrations may affect host cells. Hemolytic activity at elevated doses.

Storage Requirements

Store lyophilized at -20°C. Protect from light.

Scientific References

Quick Reference

Sequence
GIGKFLHSAKKFGKAFVGEIMNS
Molecular Weight
2466.93 g/mol
Half-Life
Short (minutes in serum)
Bioavailability
Topical; limited systemic use due to proteolysis
Research Stage
clinical phase 2
Administration
Topical or local injection